Skip to main content
SpringerLink
Log in

Rare Mycobacteria and HIV in Children: Two Case Reports

  • Research Letter
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Le Doare K, Mackie NE, Kaye S, et al. Virtual support for paediatric HIV treatment decision making. Arch Dis Child. 2015;100(6):527–31.

    Article  PubMed  Google Scholar 

  2. Haworth CS, Banks J, Capstick T, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017;72(Suppl 2):ii1–64.

    Article  PubMed  Google Scholar 

  3. Hamieh A, Tayyar R, Tabaja H, et al. Emergence of Mycobacterium simiae: a retrospective study from a tertiary care center in Lebanon. PLoS One. 2018;13(4): e0195390.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.

    Article  CAS  PubMed  Google Scholar 

  5. Teskey G, Cao R, Islamoglu H, et al. The synergistic effects of the glutathione precursor, NAC and first-line antibiotics in the granulomatous response against Mycobacterium tuberculosis. Front Immunol. 2018;9:2069.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Amaral EP, Conceicao EL, Costa DL, et al. N-Acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functions. BMC Microbiol. 2016;16(1):251.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Weiszfeiler JG, Karasseva V, Karczag E. Mycobacterium simiae and related mycobacteria. Rev Infect Dis. 1981;3(5):1040–5.

    Article  CAS  PubMed  Google Scholar 

  8. Jabbour JF, Hamieh A, Sharara SL, et al. Mycobacterium simiae: harmless colonizer or deadly pathogen? PLoS Pathog. 2020;16(4): e1008418.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Coolen-Allou N, Touron T, Belmonte O, et al. Clinical, radiological, and microbiological characteristics of Mycobacterium simiae infection in 97 patients. Antimicrob Agents Chemother. 2018;62(7):e00395–18.

  10. Al-Abdely HM, Revankar SG, Graybill JR. Disseminated Mycobacterium simiae infection in patients with AIDS. J Infect. 2000;41(2):143–7.

    Article  CAS  PubMed  Google Scholar 

  11. Hoza AS, Mfinanga SG, Rodloff AC, et al. Increased isolation of nontuberculous mycobacteria among TB suspects in Northeastern, Tanzania: public health and diagnostic implications for control programmes. BMC Res Notes. 2016;9:109.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Chung KP, Tsai TH, Huang YT, et al. Refractory bacteremia and osteomyelitis resulting in fatal bacteremic pneumonia with multiorgan failure caused by Mycobacterium simiae in a non-human immunodeficiency virus-infected adult. J Clin Microbiol. 2009;47(11):3777–9.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Shitrit D, Peled N, Bishara J, et al. Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simiae infection. Respir Med. 2008;102(11):1598–603.

    Article  PubMed  Google Scholar 

  14. Nasiri MJ, Heidary M, Azimi T, et al. Mycobacterium simiae pulmonary disease in Iran: systematic review and meta-analysis. New Microbes New Infect. 2018;26:118–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Braun-Saro B, Esteban J, Jimenez S, et al. Mycobacterium simiae infection in an immunocompromised patient without acquired immunodeficiency syndrome. Clin Infect Dis. 2002;34(5):E26–7.

    Article  PubMed  Google Scholar 

  16. Varghese B, Enani M, Shoukri M, et al. Burden of non-tuberculous mycobacterial diseases in Saudi Arabian children: the first nationwide experience. J Infect Public Health. 2019;12(6):803–8.

    Article  PubMed  Google Scholar 

  17. Feysia SG, Hasan-Nejad M, Amini S, et al. Incidence, clinical manifestation, treatment outcome, and drug susceptibility pattern of nontuberculous mycobacteria in HIV patients in Tehran, Iran. Ethiop J Health Sci. 2020;30(1):75–84.

    PubMed  PubMed Central  Google Scholar 

  18. Martinez-Barricarte R, Megged O, Stepensky P, et al. Mycobacterium simiae infection in two unrelated patients with different forms of inherited IFN-gammaR2 deficiency. J Clin Immunol. 2014;34(8):904–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Tortoli E. Microbiological features and clinical relevance of new species of the genus Mycobacterium. Clin Microbiol Rev. 2014;27(4):727–52.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Garcia-Navarro C, Garcia I, Medin G, et al. Psychosocial aspects in a cohort of vertically transmitted human immunodeficiency virus-infected adolescents. Enferm Infecc Microbiol Clin. 2014;32(10):631–7.

    Article  PubMed  Google Scholar 

  21. Lai C, Lam W, Lee MP. A case of Mycobacterium sherrisii pneumonia diagnosed by PCR/ESI-MS method. Int J Infect Dis. 2014;25:119–21.

    Article  PubMed  Google Scholar 

  22. Otchere ID, Asante-Poku A, Osei-Wusu S, et al. Isolation and characterization of nontuberculous mycobacteria from patients with pulmonary tuberculosis in Ghana. Int J Mycobacteriol. 2017;6(1):70–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Nelson M, Dockrell D, Edwards S, et al. British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. HIV Med. 2011;12(Suppl 2):1–140.

    Article  PubMed  Google Scholar 

  24. Basille D, Jounieaux V, Andrejak C. Treatment of other nontuberculous mycobacteria. Semin Respir Crit Care Med. 2018;39(3):377–82.

    Article  PubMed  Google Scholar 

  25. Cowman S, Burns K, Benson S, et al. The antimicrobial susceptibility of non-tuberculous mycobacteria. J Infect. 2016;72(3):324–31.

    Article  CAS  PubMed  Google Scholar 

  26. van Ingen J, van der Laan T, Dekhuijzen R, et al. In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands. Int J Antimicrob Agents. 2010;35(2):169–73.

    Article  PubMed  CAS  Google Scholar 

  27. Selvarangan R, Wu WK, Nguyen TT, et al. Characterization of a novel group of mycobacteria and proposal of Mycobacterium sherrisii sp. nov. J Clin Microbiol. 2004;42(1):52–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. van Ingen J, Tortoli E, Selvarangan R, et al. Mycobacterium sherrisii sp. nov., a slow-growing non-chromogenic species. Int J Syst Evol Microbiol. 2011;61(Pt 6):1293–8.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Tajan J, Espasa M, Sala M, et al. Disseminated infection by Mycobacterium sherrisii and Histoplasma capsulatum in an African HIV-infected patient. Am J Trop Med Hyg. 2013;88(5):914–7.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Santoro F, Santoro G, Del Giudice A, et al. Mycobacterium sherrisii visceral disseminated infection in an African HIV-infected adolescent. Int J Infect Dis. 2016;45:43–5.

    Article  PubMed  Google Scholar 

  31. Tortoli E. The first case of Mycobacterium sherrisii disseminated infection in a child with AIDS. AIDS. 2007;21:1496–8.

    Article  PubMed  Google Scholar 

  32. de Oliveira AC, de Araujo Filho JA. Mycobacterium sherrisii lung infection in a Brazilian patient with silicosis and a history of pulmonary tuberculosis. Case Rep Infect Dis. 2015;2015: 498608.

    Google Scholar 

  33. Borroni E, Badoum G, Cirillo DM, et al. Mycobacterium sherrisii pulmonary disease, Burkina Faso. Emerg Infect Dis. 2015;21(11):2093–4.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Gamperli A, Bosshard PP, Sigrist T, et al. Pulmonary Mycobacterium sherrisii infection in a human immunodeficiency virus type 1-infected patient. J Clin Microbiol. 2005;43(8):4283–5.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Crump JA, van Ingen J, Morrissey AB, et al. Invasive disease caused by nontuberculous mycobacteria, Tanzania. Emerg Infect Dis. 2009;15(1):53–5.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Lee SM, Myers RA, Singh K, et al. Disseminated Mycobacterium sherrisii infection in a US-born, HIV-infected patient. J Int Assoc Provid AIDS Care. 2013;12(4):245–6.

    Article  PubMed  Google Scholar 

  37. Loulergue P, Lamontagne F, Vincent V, et al. Mycobacterium sherrisii: a new opportunistic agent in HIV infection? AIDS. 2007;21(7):893–4.

    Article  PubMed  Google Scholar 

  38. Witney AA, Gould KA, Arnold A, et al. Clinical application of whole-genome sequencing to inform treatment for multidrug-resistant tuberculosis cases. J Clin Microbiol. 2015;53(5):1473–83.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Pankhurst LJ, Del Ojo EC, Votintseva AA, et al. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study. Lancet Respir Med. 2016;4(1):49–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Brown-Elliott BA, Brown JM, Conville PS, et al. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006;19(2):259–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Phillips DR, Krishnan H, Watson J. First UK report of successful treatment of Mycobacterium simiae and immune reconstitution inflammatory syndrome in an HIV-seropositive patient. Sex Transm Infect. 2008;84(4):271–2.

    Article  CAS  PubMed  Google Scholar 

  42. Bachofner JA, Ikenberg K, Schulthess B, et al. Disseminated Mycobacterium simiae and Mycobacterium avium infection causing an immune reconstitution inflammatory syndrome in a female patient with HIV infection. BMJ Case Rep. 2021;14(5):e241037.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Cevaal PM, Bekker LG, Hermans S. TB-IRIS pathogenesis and new strategies for intervention: insights from related inflammatory disorders. Tuberculosis (Edinb). 2019;118: 101863.

    Article  Google Scholar 

  44. Seddon JA, Godfrey-Faussett P, Jacobs K, et al. Hearing loss in patients on treatment for drug-resistant tuberculosis. Eur Respir J. 2012;40(5):1277–86.

    Article  PubMed  Google Scholar 

  45. Seddon JA, Johnson S, Palmer M, et al. Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment. Expert Rev Respir Med. 2021;15(2):221–37.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the following people: Dr Patricia García, Microbiologist, Medicine School, Pontificia Universidad Catolica, Chile; Dr Francisco Zúñiga, Radiologist, Hospital Exequiel Gonzalez Cortes, Chile; Dr Simon Warwick, Clinical Scientist, Public Health England, UK; Dr Joanna Danin, Consultant Radiologist, Imperial NHS Trust, UK.

Author information

Authors and Affiliations

  1. Paediatric Infectious Diseases, Imperial College Healthcare NHS Trust, London, W2 1NY, UK

    Sarah M. Johnson, Elizabeth Whittaker, Natalie Kirkhope, Onn M. Kon & Caroline Foster

  2. Imperial College London, London, UK

    Sarah M. Johnson, Elizabeth Whittaker, Onn M. Kon & Caroline Foster

  3. Centre for Clinical Microbiology, University College London, London, UK

    Giovanni Satta

  4. School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

    Cecilia Piñera & Maria Elvira Balcells

Authors
  1. Sarah M. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cecilia Piñera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elizabeth Whittaker
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Natalie Kirkhope
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Onn M. Kon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Giovanni Satta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Maria Elvira Balcells
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Caroline Foster
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah M. Johnson.

Ethics declarations

Funding

SM Johnson is funded by the Wellcome Trust grant number RSRO_P67869. This research was funded in whole, or in part, by the Wellcome Trust. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. ME Balcells is funded by ANID/CONICYT + FONDECYT Regular Grant nº 1211225.

Conflict of interest

Nil disclosed for all authors

Ethics approval

No approval required as this was a retrospective case report.

Consent to participate

Consent was sought and obtained from both cases and their families.

Consent for publication

Both cases and their families provided consent for publication.

Availability of data

Not applicable.

Code availability

Not applicable.

Author contributions

Sarah M. Johnson: Drafting of publication with substantial contributions to the manuscript and revisions. Cecilia Piñera: Drafting of publication with substantial contributions to the manuscript and revisions. Elizabeth Whittaker: Final approval of case reports and revision of manuscript for important intellectual content. Natalie Kirkhope: Final approval of the manuscript and revision of manuscript for important intellectual content. Onn M. Kon: Final approval of case reports and revision of manuscript for important intellectual content. Giovanni Satta: Final approval of case reports and revision of manuscript for important intellectual content. Maria E. Balcells: Drafting of publication, final approval of case reports and revising of manuscript for important intellectual content with substantial contributions to the paper. Caroline Foster: Drafting of publication, final approval of case reports and revising of manuscript for important intellectual content with substantial contributions to the paper. All authors consent to the publication of this article.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 385 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Johnson, S.M., Piñera, C., Whittaker, E. et al. Rare Mycobacteria and HIV in Children: Two Case Reports. Clin Drug Investig 42, 541–547 (2022). https://doi.org/10.1007/s40261-022-01153-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40261-022-01153-7

Search

Navigation